Gilead Sciences Inc. Equity-NMS: GILD

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$87.96

52W high :

$89.1

1Y :

-2.83%

5Y :

-19.05%

EPS(TTM): :

2.64

Shares O/S :

1.25 B

Market cap :

110.57 B

What is the share price of Gilead Sciences Inc. today?

Gilead Sciences Inc. (GILD) share price as of October 11, 2022, is $65.37. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Gilead Sciences Inc.?

Yes, Indian Investors can invest in the Gilead Sciences Inc. (GILD) Share by opening an international trading account with Angel One.

How can I purchase Gilead Sciences Inc. shares in India?

Purchasing Gilead Sciences Inc. (GILD) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Gilead Sciences Inc. (GILD) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Gilead Sciences Inc.?

Yes, you can purchase fractional shares of Gilead Sciences Inc. (GILD) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Gilead Sciences Inc.?

The market capitalization of Gilead Sciences Inc. on December 7, 2022, is $81.93 B.

In which sector Gilead Sciences Inc. belongs?

Gilead Sciences Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in Gilead Sciences Inc. stocks?

In order to invest in Gilead Sciences Inc. (GILD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.